Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenues	$ 1,003	$ 602
Cost of revenues	158	31
Gross profit	845	571
Sales and marketing expenses	15	61
General and administrative expenses	603	857
Research and development costs	177	212
Operating income (loss)	50	(559)
Gain from change in fair value of hybrid financial instruments	218,656	6,774
Gain from change in fair value of derivative liability - warrants	437	3,122
Gain (loss) from change in fair value of derivative liability - Series C and D Convertible Preferred Stock and debentures	23,447	(299)
Net income	242,590	9,038
Comprehensive income:
Net income	242,590	9,038
Foreign currency translation adjustment	0	111
Comprehensive income	$ 242,590	$ 9,149
Net income per common share, basic and diluted:
Basic (in dollars per share)	$ 0.049	$ 0.003
Fully diluted (in dollars per share)	$ 0.001	$ 0.000
Weighted average number of common shares:
Basic (in shares)	4,984,827,279	2,789,315,439
Fully diluted (in shares)	266,001,250,808	27,931,664,140